Sports Drug Testing Market Report 2026

The sports drug testing market size has grown rapidly in recent years. It will grow from $18.89 billion in 2025 to $22.12 billion in 2026 at a compound annual growth rate (CAGR) of 17.1%. The growth in the historic period can be attributed to increasing awareness of anti-doping regulations, increasing participation in international sporting events, increasing emphasis on fair play across professional sports, rising number of doping violations worldwide, and rising investment in sports infrastructure and athlete programs.

The sports drug testing market size is expected to see rapid growth in the next few years. It will grow to $41.16 billion in 2030 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to rising demand for accurate and rapid testing methods, growing adoption of biological passport programs, growing government support for anti-doping initiatives, growing media attention on athlete performance integrity, and growing collaboration between sports federations and testing agencies. Major trends in the forecast period include advancement in high-sensitivity testing technologies, advancement in portable on-site testing devices, advancement in long-term biomarker monitoring methods, innovation in ai-based result analysis, and innovation in genetic and molecular detection techniques.

The growing focus on athlete safety and health monitoring is expected to drive the expansion of the sports drug testing market in the coming years. Athlete safety and health monitoring involves systematically assessing athletes’ physiological, biochemical, and metabolic parameters to ensure safe participation, prevent injuries, and identify prohibited substances that may provide unfair performance advantages. This increasing focus is fueled by heightened awareness of performance-enhancing drug misuse and sports-related health risks, as organizations and athletes strive to maintain fair competition and prevent injuries. Sports drug testing supports athlete safety and health monitoring by detecting and deterring the use of performance-enhancing substances, upholding integrity in competitive sports while promoting athletes’ health and well-being. For instance, in June 2025, the International Testing Agency, a Switzerland-based independent organization, reported that over 44,400 urine and blood samples were collected from athletes representing 216 nationalities in 2024, marking an increase of more than 10% compared to 2023, with 4.6% collected out-of-competition and 45.4% during 1,100 international sports events. Consequently, the growing emphasis on athlete safety and health monitoring is fueling the growth of the sports drug testing market.

Major companies in the sports drug testing market are concentrating on developing advanced solutions, such as next-generation dried blood spot (DBS) technology, to increase efficiency, enhance user experience, and improve sample quality. Next-generation dried blood spot (DBS) technology refers to sophisticated systems created to simplify and standardize capillary blood sample collection for diagnostic testing, reducing pre-analytical errors. For instance, in February 2025, Tasso Inc., a US-based healthcare technology company, introduced the next-generation dried blood spot sample collection technology. The new product line features a compact, all-in-one device designed for nearly painless self-collection. It offers a streamlined, two-step process intended to minimize user error and ensure consistent sample quality. Additionally, it includes advanced sample stabilization chemistry and integrated tracking capabilities, providing high-quality specimens for clinical trials, remote monitoring, and decentralized diagnostics.

In January 2024, CPC LLC, a US-based provider of risk mitigation and compliance solutions, acquired Drug Free Sport International (DFSI) for an undisclosed sum. Through this acquisition, CPC intends to enhance its athlete health, safety, and compliance offerings by incorporating DFSI’s end-to-end drug-testing administration, intelligence-driven testing protocols, and comprehensive athlete wellness programs. Drug Free Sport International is a US-based company specializing in sports drug testing and anti-doping services.

Major companies operating in the sports drug testing market are UCLA Health, Kings College London, China Anti-Doping Agency (CHINADA), LGC Assure, Psychemedics Corporation, United States Anti-Doping Agency (USADA), Seibersdorf Laboratories GmbH, International Doping Test And Management AB, Qatar Anti-Doping Laboratory (QADL), Canadian Centre for Ethics in Sport (CCES), Sports Medicine Research And Testing Laboratory, Drug Free Sport International Inc., Aegis Sciences Corporation, Comprehensive Drug Testing Inc., Any Lab Test Now LLC, Clearidium Inc., Australian Sports Drug Testing Laboratory (ASDTL), Turkish Doping Control Centre, Japan Anti-Doping Agency (JADA), Brazilian Doping Control Laboratory (LBCD)

North America was the largest region in the sports drug testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sports drug testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sports drug testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have influenced the sports drug testing market by increasing costs of imported analytical instruments, assay kits, and laboratory consumables. The impact is strongest in drug testing laboratories and government departments, particularly in regions dependent on global equipment suppliers such as North America and Europe. To offset these effects, service providers are investing in local laboratory capabilities and long term supplier agreements. In some cases, tariffs have supported domestic manufacturing of testing consumables and strengthened regional testing infrastructure.

Sports drug testing involves analyzing biological samples to identify the presence of banned substances and performance-enhancing drugs in athletes. It maintains fairness and integrity in sports by detecting doping and deterring its use. The procedure employs scientific techniques and protocols to accurately monitor and report any breaches of anti-doping rules.

The primary product types in sports drug testing include equipment and consumables. Equipment encompasses devices such as urine testing devices, rapid testing devices, oral fluid testing devices, immunoassay analyzers, chromatography instruments, assay kits, and alcohol breath analyzers, which are utilized to detect banned substances in athletes. Sample types include urine, oral fluid, hair, breath, blood, and others, and they are employed by various end users such as drug testing laboratories, pain management centers, hospitals, government departments, and drug rehabilitation centers.

The sports drug testing market includes revenues earned by entities through result reporting, doping control management, and athlete education and training. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.